NCT02835846View on ClinicalTrials.gov

Investigation of the Effect of the Female Urinary Microbiome on Incontinence

PHASE4CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

March 31, 2018

Study Completion Date

May 31, 2018

Conditions
Overactive BladderIncontinenceNocturia
Interventions
DRUG

Estrogen Cream

Participants are provided a vaginal estrogen cream (i.e., Premarin Cream® 0.625 mg conjugated estrogen/gram) and instructed to use 0.5 grams with an applicator twice weekly for 12 weeks.

Trial Locations (1)

60153

Loyola University Medical Center, Maywood

All Listed Sponsors
collaborator

Kimberly-Clark Corporation

INDUSTRY

lead

Loyola University

OTHER

NCT02835846 - Investigation of the Effect of the Female Urinary Microbiome on Incontinence | Biotech Hunter | Biotech Hunter